As per this study the Global Liver Cancer Diagnostic Market was valued USD 9.71 BN (by revenue) in 2023 and is anticipated to reach USD 17.54 BN by 2032 with a CAGR of 7.67%.
Liver cancer diagnostic refers to the determination of liver cancer with the help of various test types, where liver cancer is a cancer type caused by hepatitis B and hepatitis C virus. Liver cancer diagnostic is done for both primary and secondary liver cancer. Hepatocellular carcinoma or HCC is the common type of primary liver cancer.
Market Dynamics
The growing prevalence of cancer along with increasing awareness among consumers regarding treatment is driving the market growth. Also, favorable government initiatives in order to raise awareness about liver cancer through campaigns is again fuelling market growth. In addition, the increasing prevalence of hepatitis B and hepatitis C infection is another factor accelerating the market growth. Whereas, the high cost associated with the diagnosis may hamper the market growth in the forecast timeframe. On the other hand, ongoing R&D for the advanced test for HCC diagnosis is likely to offer the opportunity in the upcoming years.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of liver cancer diagnostic.
Market Segmentation
The broad liver cancer diagnostic market has been sub-grouped into test type and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Test Type
- Laboratory Tests (Biomarkers, Blood Tests)
- Imaging
- Endoscopy
- Biopsy
- Others
By End-use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for liver cancer diagnostic in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Liver Cancer Diagnostic Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Liver Cancer Diagnostic market includes Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen N.V., Thermo Fisher Scientific Inc., Siemens Healthineers, Becton Dickinson & Company, Illumina Inc., Koninklijke Philips N.V, Epigenomics AG, Fujifilm Medical Systems U.S.A. Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.